We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Ranbaxy revenue increased 23 percent to $355 million for the first quarter of 2007 despite tempered growth in North America, according to the firm's earnings report released April 27. Read More
The lowest average price for the most frequently prescribed drugs increased at a rate nearly four times that of inflation over the last year, according to a study from Families USA. Read More
Sales of Roche's antiviral Tamiflu are on target to top the $1 billion mark this year, but the company has announced demand from government stockpiling initiatives is winding down. Read More
GlaxoSmithKline (GSK) is anticipating a second-quarter 2007 launch of Flonase follow-on Veramyst, pending FDA approval, the company said during its first-quarter earnings call. Read More
The FDA should have more power to force manufacturers to make labeling changes and conduct postmarketing clinical studies, a trade association of leading insurers said in recent recommendations. Read More
Continuing medical education (CME) programs may not be independent from inappropriate influence from the pharmaceutical industry, Senate Finance Committee Chairman Max Baucus (D-Mont.) and Sen. Chuck Grassley (R-Iowa) said. Read More
A recent study found most patients with implantable cardioverter-defibrillators (ICDs) have similar quality of life to non-ICD patients, "offsetting longstanding perceptions that the technology extends but seriously impairs patients' lives," says the University of Pennsylvania's School of Medicine, where researchers conducted the study. Read More